CUSIP No. 89413J102
|
SCHEDULE 13G
|
Page 2 of 9 Pages
|
1
|
NAMES OF REPORTING PERSONS
Quaker BioVentures, L.P.
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) o
(b) o
|
||
3
|
SEC USE ONLY
|
||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER*
0
|
|
6
|
SHARED VOTING POWER
2,564,791
|
||
7
|
SOLE DISPOSITIVE POWER
0
|
||
8
|
SHARED DISPOSITIVE POWER
2,564,791
|
||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,564,791
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
o
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9**
10.4%
|
||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
|
*
|
All share numbers and ownership percentages reported herein are as of December 31, 2011.
|
**
|
All ownership percentages reported herein are based on 24,558,845 outstanding shares of the Issuer’s common stock as of September 30, 2011.
|
CUSIP No. 89413J102
|
SCHEDULE 13G
|
Page 3 of 9 Pages
|
1
|
NAMES OF REPORTING PERSONS
Quaker BioVentures Capital, L.P.
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) o
(b) o
|
||
3
|
SEC USE ONLY
|
||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER*
0
|
|
6
|
SHARED VOTING POWER
2,564,791
|
||
7
|
SOLE DISPOSITIVE POWER
0
|
||
8
|
SHARED DISPOSITIVE POWER
2,564,791
|
||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,564,791
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
o
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9**
10.4%
|
||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
|
*
|
All share numbers and ownership percentages reported herein are as of December 31, 2011.
|
**
|
All ownership percentages reported herein are based on 24,558,845 outstanding shares of the Issuer’s common stock as of September 30, 2011.
|
CUSIP No. 89413J102
|
SCHEDULE 13G
|
Page 4 of 9 Pages
|
1
|
NAMES OF REPORTING PERSONS
Quaker BioVentures Capital, LLC
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) o
(b) o
|
||
3
|
SEC USE ONLY
|
||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER*
0
|
|
6
|
SHARED VOTING POWER
2,564,791
|
||
7
|
SOLE DISPOSITIVE POWER
0
|
||
8
|
SHARED DISPOSITIVE POWER
2,564,791
|
||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,564,791
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
o
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9**
10.4%
|
||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
|
*
|
All share numbers and ownership percentages reported herein are as of December 31, 2011.
|
**
|
All ownership percentages reported herein are based on 24,558,845 outstanding shares of the Issuer’s common stock as of September 30, 2011.
|
CUSIP No. 89413J102
|
SCHEDULE 13G
|
Page 5 of 9 Pages
|
Item 1(a)
|
Name of Issuer:
Tranzyme, Inc.
|
Item 1(b)
|
Address of Issuer’s Principal Executive Offices:
4819 Emperor Blvd., Suite 400
Durham, NC 27703
|
Item 2(a)
|
Name of Person Filing:
Quaker BioVentures, L.P.
Quaker BioVentures Capital, L.P.
Quaker BioVentures Capital, LLC
|
Item 2(b)
|
Address of Principal Business Office or, if none, Residence:
The address of the principal business office of each of the Reporting Persons is 2929 Arch Street, Cira Centre, Philadelphia, PA 19104-2868.
|
Item 2(c)
|
Citizenship:
Quaker BioVentures, L.P. – Delaware
Quaker BioVentures Capital, L.P. – Delaware
Quaker BioVentures Capital, LLC – Delaware
|
Item 2(d)
|
Title of Class of Securities:
Common Stock, $0.00001 par value per share
|
Item 2(e)
|
CUSIP Number:
89413J102
|
Item 3
|
Not applicable.
|
Item 4
|
Ownership.***
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned:
|
Quaker BioVentures, L.P. – 2,564,791
Quaker BioVentures Capital, L.P. – 2,564,791
Quaker BioVentures Capital, LLC – 2,564,791
|
CUSIP No. 89413J102
|
SCHEDULE 13G
|
Page 6 of 9 Pages
|
(b) Percent of class:
Quaker BioVentures, L.P. – 10.4%
Quaker BioVentures Capital, L.P. – 10.4%
Quaker BioVentures Capital, LLC – 10.4%
(c) Number of shares as to which the person has:
|
|
(i) Sole power to vote or to direct the vote
Quaker BioVentures, L.P. – 0
Quaker BioVentures Capital, L.P. – 0
Quaker BioVentures Capital, LLC – 0
|
|
(ii) Shared power to vote or to direct the vote
Quaker BioVentures, L.P. – 2,564,791
Quaker BioVentures Capital, L.P. – 2,564,791
Quaker BioVentures Capital, LLC – 2,564,791
|
|
(iii) Sole power to dispose or to direct the disposition of
Quaker BioVentures, L.P. – 0
Quaker BioVentures Capital, L.P. – 0
Quaker BioVentures Capital, LLC – 0
|
|
(iv) Shared power to dispose or to direct the disposition of
Quaker BioVentures, L.P. – 2,564,791
Quaker BioVentures Capital, L.P. – 2,564,791
Quaker BioVentures Capital, LLC – 2,564,791
|
|
Quaker BioVentures Capital, L.P. is the general partner of Quaker BioVentures, L.P.; Quaker BioVentures Capital, LLC is the general partner of Quaker BioVentures Capital, L.P.
|
|
Item 5
|
Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following o.
|
Item 6
|
Ownership of More than Five Percent on Behalf of Another Person.
Not applicable.
|
|
CUSIP No. 89413J102
|
SCHEDULE 13G
|
Page 7 of 9 Pages
|
Item 7
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not applicable.
|
Item 8
|
Identification and Classification of Members of the Group.
Each of the Reporting Persons may be deemed to be a member of a group with respect to the issuer or securities of the issuer for the purpose of Section 13(d) or 13(g) of the Securities Exchange Act of 1934, as amended.
|
Item 9
|
Notice of Dissolution of Group.
Not applicable.
|
Item 10
|
Certification.
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
|
CUSIP No. 89413J102
|
SCHEDULE 13G
|
Page 8 of 9 Pages
|
Date: February 14, 2012
|
QUAKER BIOVENTURES, L.P.
By: Quaker BioVentures Capital, L.P., its general partner
By: Quaker BioVentures Capital, LLC, its general partner
/s/ Richard S. Kollender
Name: Richard S. Kollender
Title: Vice President
|
QUAKER BIOVENTURES CAPITAL, L.P.
By: Quaker BioVentures Capital, LLC, its general partner
/s/ Richard S. Kollender
Name: Richard S. Kollender
Title: Vice President
|
|
QUAKER BIOVENTURES CAPITAL, LLC
/s/ Richard S. Kollender
Name: Richard S. Kollender
Title: Vice President
|
CUSIP No. 89413J102
|
SCHEDULE 13G
|
Page 9 of 9 Pages
|
QUAKER BIOVENTURES, L.P.
By: Quaker BioVentures Capital, L.P., its general partner
By: Quaker BioVentures Capital, LLC, its general partner
/s/ Richard S. Kollender
Name: Richard S. Kollender
Title: Vice President
|
|
QUAKER BIOVENTURES CAPITAL, L.P.
By: Quaker BioVentures Capital, LLC, its general partner
/s/ Richard S. Kollender
Name: Richard S. Kollender
Title: Vice President
|
|
QUAKER BIOVENTURES CAPITAL, LLC
/s/ Richard S. Kollender
Name: Richard S. Kollender
Title: Vice President
|